ChemPartner PharmaTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	430.69	411.83	368.33	347.26	761.66	160.46
Trading Asset Securities	33.99	45.57	1.05	2.21	-	18.98
Cash & Short-Term Investments	464.68	457.39	369.37	349.47	761.66	179.44
Cash Growth	31.95%	23.83%	5.70%	-54.12%	324.46%	-35.73%
Accounts Receivable	243.73	238.3	199.01	268.11	349.87	372.28
Other Receivables	5.24	6.91	12.06	12.01	87.18	8.49
Receivables	248.97	245.2	211.07	280.12	437.06	380.77
Inventory	16.58	9.47	11.44	27.88	42.82	68.81
Prepaid Expenses	-	4.77	0.87	11.03	-	-
Other Current Assets	58.64	48.18	51.31	58.68	38.82	58.72
Total Current Assets	788.86	765.02	644.07	727.18	1,280	687.74
Property, Plant & Equipment	600.46	617.45	683.88	851.39	973.62	1,512
Long-Term Investments	189.53	185.51	214.46	199.79	197.02	175.96
Goodwill	-	-	-	139.26	858.86	1,207
Other Intangible Assets	32.9	32.69	30.66	30.05	55.66	148.61
Long-Term Deferred Tax Assets	52.42	46.75	39.46	40.45	10.66	4.89
Long-Term Deferred Charges	227.28	238.13	267.09	324.36	370.23	385.02
Other Long-Term Assets	148.6	147.39	116.18	121.85	77.49	96.39
Total Assets	2,040	2,033	1,996	2,434	3,824	4,218
Accounts Payable	58.75	50.31	64.02	53.79	80.7	108.38
Accrued Expenses	50.69	99.83	58.19	82.78	100.26	90.66
Short-Term Debt	67.4	67.32	58.47	60	115.02	158.57
Current Portion of Long-Term Debt	-	8.28	6.52	4.3	111.47	330.13
Current Portion of Leases	66.52	59.63	73.98	69.63	67.24	72.83
Current Income Taxes Payable	7.47	3.62	4.61	5.42	49.85	8.6
Current Unearned Revenue	41.3	46.51	41.93	77.21	78.26	57.59
Other Current Liabilities	77.48	19.95	38.97	73.63	129.24	163.91
Total Current Liabilities	369.61	355.45	346.7	426.77	732.03	990.66
Long-Term Debt	28.87	28.92	37.2	43.67	177.21	614.92
Long-Term Leases	288.31	307.9	337.13	457.73	495.25	570.58
Long-Term Unearned Revenue	22.26	23.46	28.36	27.43	16.41	20.47
Long-Term Deferred Tax Liabilities	3.26	3.3	2.88	12.58	12.01	26.07
Other Long-Term Liabilities	16.28	13.57	5.47	5.24	5.02	5.81
Total Liabilities	728.59	732.59	757.75	973.44	1,438	2,229
Common Stock	497.96	497.96	497.96	499.78	499.78	499.78
Additional Paid-In Capital	1,288	1,260	1,205	1,229	1,229	1,229
Retained Earnings	-515.67	-497.51	-510.92	-284.45	648.27	269.68
Treasury Stock	-	-	-	-25.51	-25.51	-20.44
Comprehensive Income & Other	11.54	15.99	21.33	17.64	9.81	-13.76
Total Common Equity	1,282	1,276	1,214	1,437	2,362	1,964
Minority Interest	29.29	24.34	24.2	24.24	24.43	24.63
Shareholders' Equity	1,311	1,300	1,238	1,461	2,386	1,989
Total Liabilities & Equity	2,040	2,033	1,996	2,434	3,824	4,218
Total Debt	451.1	472.04	513.31	635.34	966.2	1,747
Net Cash (Debt)	13.58	-14.65	-143.93	-285.88	-204.53	-1,568
Net Cash Per Share	0.03	-0.03	-0.29	-0.57	-0.41	-3.16
Filing Date Shares Outstanding	497.96	497.96	497.96	497.96	497.96	498.33
Total Common Shares Outstanding	497.96	497.96	497.96	497.96	497.96	498.33
Working Capital	419.25	409.57	297.37	300.4	548.33	-302.91
Book Value Per Share	2.57	2.56	2.44	2.89	4.74	3.94
Tangible Book Value	1,249	1,243	1,183	1,267	1,447	608.37
Tangible Book Value Per Share	2.51	2.50	2.38	2.55	2.91	1.22
Buildings	-	102.02	102.02	103.1	52.82	238.54
Machinery	-	623.63	609.96	554.12	464.19	791.09
Construction In Progress	-	4.07	13	7.96	75.36	235.74